4 completed, 1 terminated. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow safinamide: new trials by email Literature Review of safinamide trials Research Report on safinamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safinamide for Multiple System Atrophy (MSA) Safinamide Methanesulfonate, Safinamide Methanesulfonate matching placebo - Multiple System Atrophy | Phase 2 | Completed | Zambon SpA | 49 | 2019-10-29 | 2021-10-13 |
| A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging Safinamide - Parkinson Disease | Phase 2 | Terminated | Newron Pharmaceuticals SPA | 5 | 2011-03-01 | 2017-09-18 |
| A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease safinamide, placebo - Parkinson's Disease With Cognitive Impairments | Phase 2 | Completed | Newron Pharmaceuticals SPA | 103 | 2010-09-01 | 2013-03-29 |
| Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects Placebo, Safinamide - Parkinson's Disease | Phase 2 | Completed | Newron Pharmaceuticals SPA | 26 | 2010-04-01 | 2013-03-29 |
| A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics Safinamide + Levodopa, Placebo + Levodopa - Idiopathic Parkinson's Disease | Phase 1 / Phase 2 | Completed | Newron Pharmaceuticals SPA | 24 | 2009-09-01 | 2013-03-29 |
Parkinson Disease (4) · Multiple System Atrophy (1) · Thyroid Dyshormonogenesis 2A (1)
Newron Pharmaceuticals SPA (4) · Zambon SpA (1)
Italy (2) · Spain (2) · United States (2) · Austria (1) · Canada (1) · France (1) · Germany (1) · South Africa (1)
Charlotte Keywood, MD (1) · Jonathan Willmer, MD (1) · Jonathan Willmer, MD, FRCPC (1) · Kenneth Marek, MD (1)
2018 (1)